GW Pharmaceuticals PLC EBITDA Margin 2016-2021 | GWPH
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for GW Pharmaceuticals PLC (GWPH) over the last 10 years. The current EBITDA margin for GW Pharmaceuticals PLC as of March 31, 2021 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2021-03-31 | $0.56B | $-0.05B | -9.14% |
| 2020-12-31 | $0.53B | $-0.04B | -7.40% |
| 2020-09-30 | $0.49B | $-0.04B | -7.79% |
| 2020-06-30 | $0.44B | $-0.04B | -9.95% |
| 2020-03-31 | $0.39B | $-0.07B | -16.54% |
| 2019-12-31 | $0.31B | $-0.11B | -35.05% |
| 2019-06-30 | $0.11B | $-0.15B | -136.28% |
| 2019-03-31 | $0.04B | $-0.21B | -468.18% |
| 2018-09-30 | $0.02B | $-0.22B | -1343.75% |
| 2018-06-30 | $0.02B | $-0.20B | -1152.94% |
| 2018-03-31 | $0.02B | $-0.16B | -1018.75% |
| 2017-12-31 | $0.02B | $-0.09B | -587.50% |
| 2017-06-30 | $0.01B | $-0.13B | -1136.36% |
| 2017-03-31 | $0.01B | $-0.10B | -800.00% |
| 2016-12-31 | $0.02B | $-0.05B | -300.00% |
